Metabolic and cardiovascular genes in polycystic ovary syndrome: A candidate-wide association study (CWAS)

Steroids

Volumn 77, Issue 4, 2012, Pages 317-322

  Jones, Michelle R ^a   Chua, Angela K ^a   Mengesha, Emebet A ^a   Taylor, Kent D ^a   Chen, Yii Der I ^a   Li, Xiaohui ^a   Krauss, Ronald M ^c   Rotter, Jerome I ^a,b   Legro, Richard S ^d   Azziz, Ricardo ^a,b,e   Goodarzi, Mark O ^a,b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Candidate wide association study; Cardio Metabochip; Genetic association; Polycystic ovary syndrome; Single nucleotide polymorphism

Indexed keywords

ADULT; CASE CONTROL STUDY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; BODY HEIGHT; CARDIOVASCULAR SYSTEM; COHORT STUDIES; DIABETES COMPLICATIONS; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEUKOCYTE COUNT; LIPID METABOLISM; MIDDLE AGED; PLATELET COUNT; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84857061970     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.12.005     Document Type: Conference Paper

References (44)

1. R.S. Legro, D. Driscoll, J.F. Strauss, J. Fox, and A. Dunaif Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome Proc Natl Acad Sci USA 95 1998 14956 14960 (Pubitemid 29003738)
2. J.M. Vink, S. Sadrzadeh, C.B. Lambalk, and D.I. Boomsma Heritability of polycystic ovary syndrome in a Dutch twin-family study J Clin Endocrinol Metab 91 2006 2100 2104 (Pubitemid 43854989)
3. Z.J. Chen, H. Zhao, L. He, Y. Shi, Y. Qin, and Y. Shi Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3 Nat Genet 43 2011 55 59
4. M.O. Goodarzi, D.A. Dumesic, G. Chazenbalk, and R. Azziz Polycystic ovary syndrome: etiology, pathogenesis and diagnosis Nat Rev Endocrinol 7 2011 219 231
5. L.J. Shaw, C.N. Bairey Merz, R. Azziz, F.Z. Stanczyk, G. Sopko, and G.D. Braunstein Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health-National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation J Clin Endocrinol Metab 93 2008 1276 1284 (Pubitemid 351519721)
6. S.S. Rich, J.M. Norris, and J.I. Rotter Genes associated with risk of type 2 diabetes identified by a candidate-wide association scan: as a trickle becomes a flood Diabetes 57 2008 2915 2917
7. J. Zawadzki, and A. Dunaif Diagnostic criteria for polycystic ovary syndrome: towards a rational approach A. Dunaif, J.R. Givens, F.P. Haseltine, G.R. Merriam, Polycystic ovary syndrome 1992 Blackwell Scientific Boston 377 384
8. R. Azziz, K.S. Woods, R. Reyna, T.J. Key, E.S. Knochenhauer, and B.O. Yildiz The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745 2749 (Pubitemid 38766360)
9. R.S. Legro, E.R. Myers, H.X. Barnhart, S.A. Carson, M.P. Diamond, and B.R. Carr The Pregnancy in Polycystic Ovary Syndrome study: baseline characteristics of the randomized cohort including racial effects Fertil Steril 86 2006 914 933 (Pubitemid 44485050)
10. J.A. Simon, F. Lin, S.B. Hulley, P.J. Blanche, D. Waters, and S. Shiboski Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study Am J Cardiol 97 2006 843 850
11. K.L. Gunderson, F.J. Steemers, G. Lee, L.G. Mendoza, and M.S. Chee A genome-wide scalable SNP genotyping assay using microarray technology Nat Genet 37 2005 549 554 (Pubitemid 40617286)
12. K.L. Gunderson, F.J. Steemers, H. Ren, P. Ng, L. Zhou, and C. Tsan Whole-genome genotyping Methods Enzymol 410 2006 359 376 (Pubitemid 44287014)
13. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, and D. Bender PLINK: a tool set for whole-genome association and population-based linkage analyses Am J Hum Genet 81 2007 559 575 (Pubitemid 47330214)
14. J. Nestler, D.J. Jakubowicz, A. Falcon de Vargas, C. Brik, N. Quintero, and F. Medina Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositoglycan mediators as the signal transduction system J Clin Endocrinol Metab 83 1998 2001 2005 (Pubitemid 28496328)
15. D. Willis, and S. Franks Insulin action in human granulosa cells from normal and polycystic ovaries is mediated by the insulin receptor and not the the type-I insulin-like growth factor receptor J Endocrinol Metabo 80 1995 3788 3790
16. C. Bergh, B. Carlsson, J.H. Olsson, U. Selleskog, and T. Hillensjo Regulation of androgen production in cultured human thecal cells by insulin-like growth factor I and insulin Fertil Steril 59 1993 323 331 (Pubitemid 23057784)
17. S. Franks, C. Gilling-Smith, H. Watson, and D. Willis Insulin action in the normal and polycystic ovary Endocrinol Metab Clin North Am 28 1999 361 378 (Pubitemid 29242718)
18. P.S. Sharp, D.S. Kiddy, M.J. Reed, V. Anyaoku, D.G. Johnston, and S. Franks Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome Clin Endocrinol (Oxf) 35 1991 253 257
19. M.I. McCarthy Genomics, type 2 diabetes, and obesity N Engl J Med 363 2010 2339 2350
20. J. Hebebrand, A.L. Volckmar, N. Knoll, and A. Hinney Chipping away the 'missing heritability': GIANT steps forward in the molecular elucidation of obesity - but still lots to go Obes Facts 3 2010 294 303
21. S. Kathiresan, B.F. Voight, S. Purcell, K. Musunuru, D. Ardissino, and P.M. Mannucci Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants Nat Genet 41 2009 334 341
22. A. Demirkan, N. Amin, A. Isaacs, M.R. Jarvelin, J.B. Whitfield, and H.E. Wichmann Genetic architecture of circulating lipid levels Eur J Hum Genet 19 2011 813 819
23. J.L. San-Millan, and H.F. Escobar-Morreale The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence Clin Endocrinol (Oxf) 72 2010 383 392
24. T.M. Barber, A.J. Bennett, C.J. Groves, U. Sovio, A. Ruokonen, and H. Martikainen Disparate genetic influences on polycystic ovary syndrome (PCOS) and type 2 diabetes revealed by a lack of association between common variants within the TCF7L2 gene and PCOS Diabetologia 50 2007 2318 2322 (Pubitemid 47512408)
25. A. Biyasheva, R.S. Legro, A. Dunaif, and M. Urbanek Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2 J Clin Endocrinol Metab 94 2009 2617 2625
26. P. Christopoulos, G. Mastorakos, M. Gazouli, D. Panidis, E. Deligeoroglou, and I. Katsikis Genetic variants in TCF7L2 and KCNJ11 genes in a Greek population with polycystic ovary syndrome Gynecol Endocrinol 24 2008 486 490
27. X. Liu, L. Li, Z.J. Chen, Z. Lu, Y. Shi, and Y. Zhao Genetic variants of cyclin-dependent kinase 5 regulatory subunit associated protein 1-like 1 and transcription factor 7-like 2 are not associated with polycystic ovary syndrome in Chinese women Gynecol Endocrinol 26 2010 129 134
28. S. Tan, A. Scherag, O.E. Janssen, S. Hahn, H. Lahner, and T. Dietz Large effects on body mass index, insulin resistance of fat mass, obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS) BMC Med Genet 11 2010 12
29. P. Xu, Y. Che, Y. Cao, X. Wu, H. Sun, and F. Liang Polymorphisms of TCF7L2 and HHEX genes in Chinese women with polycystic ovary syndrome J Assist Reprod Genet 27 2010 23 28
30. R. Attaoua, S. Ait El Mkadem, S. Radian, S. Fica, F. Hanzu, and A. Albu FTO gene associates to metabolic syndrome in women with polycystic ovary syndrome Biochem Biophys Res Commun 373 2008 230 234
31. T.M. Barber, A.J. Bennett, C.J. Groves, U. Sovio, A. Ruokonen, and H. Martikainen Association of variants in the fat mass and obesity associated (FTO) gene with polycystic ovary syndrome Diabetologia 51 2008 1153 1158
32. K.G. Ewens, M.R. Jones, W. Ankener, D.R. Stewart, M. Urbanek, A. Dunaif, and F. TO MC4R gene variants are associated with obesity in polycystic ovary syndrome PLoS One 6 2011 e16390
33. I. Kowalska, M.T. Malecki, M. Straczkowski, J. Skupien, M. Karczewska-Kupczewska, and A. Nikolajuk The FTO gene modifies weight, fat mass and insulin sensitivity in women with polycystic ovary syndrome, where its role may be larger than in other phenotypes Diabetes Metab 35 2009 328 331
34. E. Wehr, N. Schweighofer, R. Moller, A. Giuliani, T.R. Pieber, and B. Obermayer-Pietsch Association of FTO gene with hyperandrogenemia and metabolic parameters in women with polycystic ovary syndrome Metabolism 59 2010 575 580
35. Q. Yan, J. Hong, W. Gu, Y. Zhang, Q. Liu, and Y. Su Association of the common rs9939609 variant of FTO gene with polycystic ovary syndrome in Chinese women Endocrine 36 2009 377 382
36. T.M. Barber, A.J. Bennett, A.L. Gloyn, C.J. Groves, U. Sovio, and A. Ruokonen Relationship between E23K (an established type II diabetes- susceptibility variant within KCNJ11), polycystic ovary syndrome and androgen levels Eur J Hum Genet 15 2007 679 684 (Pubitemid 46825058)
37. L. Li, Y. Zhao, L. Wang, J. Yan, and Z.J. Chen Genetic variations of solute carrier family 30 (zinc transporter) member 8 (SLC30A8) are not associated with polycystic ovary syndrome Fertil Steril 91 2009 1598 1601
38. K. Wang, L. You, Y. Shi, L. Wang, M. Zhang, and Z.J. Chen Association of genetic variants of insulin degrading enzyme with metabolic features in women with polycystic ovary syndrome Fertil Steril 90 2008 378 384
39. K.G. Ewens, M.R. Jones, W. Ankener, D.R. Stewart, M. Urbanek, and A. Dunaif Type 2 diabetes susceptibility single-nucleotide polymorphisms are not associated with polycystic ovary syndrome Fertil Steril 95 2011 2538 2541
40. L. Shi, S. Ko, S. Kim, I. Echchgadda, T.S. Oh, and C.S. Song Loss of androgen receptor in aging and oxidative stress through Myb protooncoprotein- regulated reciprocal chromatin dynamics of p53 and poly(ADP-ribose) polymerase PARP-1 J Biol Chem 283 2008 36474 36485
41. Holmes KA, Hurtado A, Brown GD, Launchbury R, Ross-Innes CS, Hadfield J, et al. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proc Natl Acad Sci USA 2011; [Epub May 2].
42. L.H. Pojoga, P.C. Underwood, M.O. Goodarzi, J.S. Williams, G.K. Adler, and X. Jeunemaitre Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension J Clin Endocrinol Metab 96 2011 E1288 E1292
43. E. Zeggini, M.N. Weedon, C.M. Lindgren, T.M. Frayling, K.S. Elliott, and H. Lango Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes Science 316 2007 1336 1341 (Pubitemid 46871654)
44. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls Nature 447 2007 661 678